20 May 2013
13 April 1992
The US pharmaceutical industry will continue to face growing resistance from the federal government and also from private forces towards...
13 April 1992
The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...
13 April 1992
Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...
13 April 1992
A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...
6 April 1992
The costs of depression to the National Health Service in the UK are L 333 million per year, according to...
6 April 1992
The US concern Roberts Pharma-ceutical has reached a definitive agreement to acquire the National Clinical Research Centers in the USA...
6 April 1992
Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...
6 April 1992
Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...
6 April 1992
Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...
6 April 1992
Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...